Midwest Region Cancer Control Research Network is categorized under Medical Research in Chicago, IL and active since 1993.
Midwest Region Cancer Control Research Network was established in 1993, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Nyambi Ebie at the company’s single location by writing to 1603 West Taylor St, Chicago, Illinois IL 60612 or by phoning (312) 996-4865. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Midwest Region Cancer Control Research Network |
Contact Person: | Nyambi Ebie |
Address: | 1603 West Taylor St, Chicago, Illinois 60612 |
Phone Number: | (312) 996-4865 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1993 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
Midwest Region Cancer Control Research Network was started in 1993 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Nyambi Ebie for inquiries that concern Midwest Region Cancer Control Research Network by calling the company number (312) 996-4865, as your correspondence is most welcome. Additionally, the physical location of the single location of Midwest Region Cancer Control Research Network can be found at the coordinates as well as the street address 1603 West Taylor St in Chicago, Illinois 60612.
For its online presence, you may visit Midwest Region Cancer Control Research Network’s website at and engage with its social media outlets through on Twitter and on Facebook.